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Abstract
Background: The persistence of latently Human immunodeficiency virus-1 (HIV-1) infected cellular reservoirs in
resting CD4
+ T cells is a major obstacle to HIV-1 eradication. The detailed mechanism of HIV-1 latency remains
unclear. We investigated histones and their post-translational modification associated with HIV-1 latency in novel
HIV-1 latently infected cell lines established previously, NCHA cells.
Methods: To examine histones and their modification linked with HIV-1 latency, the expression profiles for core
histone proteins and histone deacetylases (HDACs) in NCHA cells were characterized by RT-PCR, ELISA, and western
blot. The levels of histone acetylation and methylation at histone H3 Lys
9 (H3K9) and Lys
27 (H3K27) in HIV-1 latently
infected cells were analyzed by western blot and chromatin immunoprecipitation-sequencing (ChIP-seq).
Results: The expression levels for four core histone proteins (H2A, H2B, H3 and H4) and HDACs (HDAC1-8) in
NCHA cells were not significantly different from those in their parental cells. Histone H3K9 and H3K27 acetylations
in NCHA cells showed no difference in parental and NCHA cells, whereas the levels of di- and tri-methylation were
increased in NCHA cells. The expression of EED which is a component of polycomb repressive complex 2 (PRC2),
and BMI1 and RING2 which are constituents of PRC1, were upregulated in NCHA cells. In addition, more
ubiquitylation at histone H2A was detected in NCHA cells.
Conclusions: Our results suggest that tri-methylation of histone H3K27 and H2A ubiquitylation via polycomb
group protein may play a crucial role in epigenetic silencing accounting for HIV-1 latency in NCHA cells.
Background
HIV-1 can evade the immune responses of host cells
and establish latent infection among HIV-infected
patients, which leads to AIDS despite treatment referred
to a highly active antiretroviral therapy (HAART).
Latently infected memory T cells, which are generally
established within days of the initial infection, are very
rare (~1 million) in a patient and have a long half-life of
over 44 months on average. The complete elimination
of HIV reservoirs seems to take over 60 years under the
HAART regimen [1].
In some HIV-1 latency studies, phosphorylation of
NF-B p65 activates the long terminal repeat (LTR) of
HIV-1 provirus in latent cells directly, which in turn
drives HIV-1 transcription. Phosphorylation of p65 at
ser
276 enhances the recruitment of coactivator p300/
HAT, leading to increased transcriptional activation in
NF-B dependent genes by the acetylation of histones
[2,3]. NF-B p50/HDAC complexes which constitutively
bind to the HIV-1 LTR and maintain HIV latency can
be depleted from the latent HIV promoter upon TNF-a
induction [4]. Even if some researchers have reported
that HDACs play a critical role in HIV-1 latency, mole-
cular mechanisms involved in HIV-1 latency should be
further explored for complete eradication of HIV.
The eukaryotic genome is organized into the highly
complex nucleoprotein structure of chromatin. Epige-
netic studies show that this chromatin structure can be
modified by DNA methylation, covalent histone modifi-
cations, and nucleosome remodeling. In particular, his-
tone proteins consisting of the nucleosome core are
subject to modifications such as methylation, acetyla-
tion, ubiquitylation, sumoylation, and phosphorylation
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any medium, provided the original work is properly cited.on specific residues [5]. Posttranslational modifications
of core histones change their interactions with DNA
and thus involve in diverse biological processes such as
DNA repair, chromosome condensation, and gene regu-
l a t i o n .S p e c i f i c a l l y ,h i s t o n eH 3L y s
4 tri-methylation
(H3K4me3) is mostly enriched at active gene promoters,
whereas histone H3K9 and H3K27 di-/tri-methylation
(H3K9me2/me3 and H3K27me2/me3) are highly
enriched at inactive loci in mammalian cells [6].
Recent cancer studies show that broad alteration of
gene activation or silencing by epigenetic alterations
can lead to cancer development and carcinogenesis [7].
Elevated expression levels of some histone methyl-
transferase such as EZH2 and G9a are associated with
breast and liver cancers [8,9]. It has been suggested
that HIV-1 latency is strongly associated with chroma-
tin silencing and that novel drug development can be
based on the chromatin modification like acetylation/
deacetylation and methylation as new targets for HIV-
1 therapy [1,10,11]. Recently, it was reported that G9a,
one of histone methyltransferase, and p-TEFb contri-
bute to the maintenance and establishment of HIV-1
latency [12,13]. In our previous study, HIV-1 latently
infected cells also showed distinctly different patterns
in histone H3K9 and H3K27 modification from those
in their HIV-uninfected parental cells (unpublished
data). Based on these findings, we tried to figure out
the detailed mechanisms of HIV-1 silencing in the cel-
lular reservoirs for curing HIV-1 infection from AIDS
patients in the future.
Materials and methods
Cell lines
Reference cell lines, A3.01 cells and ACH2 cells, were
obtained from the National Institutes of Health AIDS
Research and Reference Reagent Program. Latently
infected A3.01-derived cell lines, NCHA1 and NCHA2,
were established from our laboratory [14]. Cells were
cultured in RPMI 1640 culture medium supplemented
with 10% fetal bovine serum (FBS), 5% penicillin/strep-
tomycin, and 2mM glutamine at 37°C in humidified 5%
CO2 incubator.
RNA extraction and RT-PCR
TRIZol reagent (Invitrogen, USA) was used for isolation
of RNA according to the manufacturer’sp r o t o c o l .
Extracted RNA was stored at -20°C prior to use for RT-
PCR. Total RNA (2ug) collected from each cell line was
reverse transcribed to cDNA with Superscript II Reverse
Transcriptase (Invitrogen) and an oligo(dT) primer.
Preparation of nuclear extracts
Nuclear extracts were prepared with Nuclear Extraction
Kit (Panomics, USA) and protein concentration of these
nuclear extracts was measured with Protein DC assay
Kit (Bio-Rad, USA) according to the manufacturer’s pro-
tocol. Nuclear extracts were applied to ELISA assay
immediately and the rest we r es t o r e da t- 8 0 ° Cp r i o rt o
use.
ELISA assay for histone acetylation
Acetylation levels of four core histones were measured
with Pathscan Acetyl His t o n eH 2 A ,H 2 B ,H 3a n dH 4
Sandwich ELISA Kit (Cell Signaling, USA) according to
the manufacturer’s instruction.
Western blot analysis
To identify HDAC proteins, total cellular protein
extracts were prepared in ice-cold RIPA buffer (50 mM
Tris pH 7.5, 0.5% deoxycholate, 0.5% NP-40, 0.5% SDS,
and 100 mM NaCl) supplemented with fresh Com-
plete™ protease inhibitor cocktail (Roche, Swiss). Pro-
tein extracts were separated by SDS-PAGE, transferred
to an Immobilon™-P membrane (Millipore, USA), and
probed with specific antibodies (H2A~ H4, HDACs and
EED, Abcam, USA; ubiquitylated H2A, Millipore, USA).
GAPDH (#2118, cell signaling, USA) and Lamin B (sc-
20682, Santa Cruz, USA) were used as protein loading
control. After incubation with the HRP-conjugated sec-
ondary antibody, proteins were visualized using West
Pico chemiluminescence substrate (Pierce, USA) accord-
ing to the manufacture’s protocol.
Immunoprecipitation
Immunoprecipitation was performed using IP Kit
(Active motif, USA) with mouse anti-BMI1 (ab14389,
Abcam, USA). The interaction of RING2 with BMI1
was examined with western blot using rabbit anti-
RING2 (ab28629, Abcam, USA).
Chromatin immunoprecipitation (ChIP)
Chromatin from uninfected and latently infected CD4+
T cells was digested with micrococcal nuclease into
nucleosome-size unit. ChIP was performed using antibo-
dies to histone H3K4me3 (ab8580, Abcam, USA),
H3K9me3 (ab8898, Abcam, USA), H3K27me3 (07-449,
Millipore, USA), and H3K9ac (ab4441, Abcam, USA).
Following treatment of proteinase K, the DNA frag-
ments were purified by phenol/chloroform extraction
and ethanol precipitation.
Genomic DNA library construction for ChIP-Seq and data
analysis
The DNA sequencing library preparation and sequen-
cing on the Genome Analyzer II were performed
according to the manufacturer’s instruction (Illumina,
USA). Briefly, the ChIPed DNA was polished by blunt-
ing and ‘A’-base addition followed by adapter ligation.
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Page 2 of 7After sequencing, the GA pipeline 1.4 software provided
by Illumina was used for image analysis, base calling,
and sequence alignment. The uniquely aligned sequence
tags to the human genome (hg18/NCBI build 36) were
used in further analysis. The sequence tags were
counted in promoters (transcription start site ± 1kb),
genebodies (from transcription start site + 1kb to tran-
scription end site), and intergenic regions. To analyze
the enrichment patterns of histone modifications on
HIV-1 provirus, we aligned the sequencing tags to the
HIV-1 genome and counted tags in a non-0verlapping
200bp window.
Results
Histone and HDAC levels in NCHA cells were not
significantly different
The expression and acetylation levels of four core his-
tones (H2A, H2B, H3 and H4) in NCHA cells did not
exhibit significant differences as shown in Figrue 1A
and 1B, respectively. The mRNA levels for HDACs in
C l a s sI( H D A C 1 ,2 ,3 ,a n d8 )w e r em e a s u r e db yR T -
PCR analysis shown in Figure 1C. Both Class I and
Class II HDACs (HDAC4, 6, and 7; data not shown) did
not show any significant difference in parental and
latently HIV-1 infected cells. The protein levels of
HDAC1 - 3 in ACH2 and NCHA cells were relatively
similar to those observed in their parent cells (Figure
1D; data not shown for HDAC4, 6, 7 and 8).
Histone methylations were highly enriched in NCHA cells
As shown in Figure 2A, the levels of di- and trimethyla-
tion of histone H3K9 and H3K27 were dramatically ele-
vated in NCHA cells except ACH2 cells. To determine
whether the elevation of H3K9me3 and H3K27me3
levels were biased in specific genomic regions, the gen-
ome-wide distribution of modifications were examined
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Į-H3
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Į- Lamin B
(A) (B)
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Figure 1 Histone and HDAC profiles in HIV-1 latently infected A3.01derived cells. A) Expression levels of four core histone proteins were
investigated by western blot. Thirty ug of nuclear extract were loaded and immunoblotted using antibodies specific to H2A, H2B, H3 and H4.
Anti-laminB was used as a loading control. B) The acetylation levels of four core histone proteins were quantified using the H2A-, H2B-, H3- and
H4 -PathScan acetylated histone sandwich ELISA kit. Error bar represent the S.D. from the mean. C) mRNA levels of HDACs in each cell line were
measured with reverse transcriptase PCR (RT-PCR). GAPDH was used as a control. D) Protein levels of HDAC1, HDAC2 and HDAC3 were
investigated by western blot using 30 ug of nuclear extract. Anti-laminB was used as a loading control.
Kim et al. Virology Journal 2011, 8:179
http://www.virologyj.com/content/8/1/179
Page 3 of 7using all RefSeq genes (Figure 2B). H3K4me3 and
H3K9ac were highly enriched in promoter regions,
whereas H3K9me3 and H3K27me3 were distributed
over the gene bodies and intergenic regions. However,
the overall population was not significantly changed in
ACH2 and NCHA cells compared with those of the
A3.01 cells. The histone modification patterns of the
HIV-1 proviral genomes showed that H3K9me3 was
enriched in latently infected cell lines (ACH2, NCHA1,
and NCHA2) shown in Figure 2C but H3K27me3 was
not (data not shown).
Polycomb group might induce HIV-1 gene silencing
To understand HIV-1 latency related with gene silencing
by polycomb group protein complex, we examined the
expression levels of polycomb group proteins in NCHA
cells. Firstly, the expression level of EED, which is part
of PRC2 that recognizes histone H3K27 and/or H3K9
residues for histone methylation, was investigated by
western blot using an antibody specific to EED. As
shown in Figure 3A, the expression of EED was upregu-
lated in NCHA cells. Secondly, the expression levels of
BMI1 and RING2, which are components of PRC1 that
recognizes and binds to PRC2, were also increased in
the nuclear fraction of NCHA cells compared with their
parent cells and the interaction between these two pro-
teins was confirmed by coimmunoprecipitation (Figure
3B). Finally, ubiquitylation levels of NCHA cells on his-
tone H2A were also enriched compared with the parent
cells (Figure 3C). These results suggest that PRC-
Figure 2 Gene silencing by polycomb group-proteins in NCHA cells for HIV-1 latency. A) Methylation levels of histone H3 on the specific
lysine residues were measured by western blot. In each lane, 30 ug of nuclear extract were used and the antibodies were indicated on the
right. Anti-laminB was used as a loading control. B) Global distributions of histone modifications were examined by ChIP-Seq. Promoters were
the regions of 1 kb upstream and downstream of the transcription start site, and gene body was defined as the length from 1 kb downstream
of the transcription start site to transcription end site and the remaining regions were intergenic regions. C) The H3K9me3 profile was shown on
HIV-1 provirus genome. The X axis represents the HIV-1 genomic position and the Y axis indicates the normalized tag count which is calculated
by total tag numbers detected in a 1 kb window divided by total sequenced tag number.
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quitylation may contribute to HIV-1 gene silencing in
NCHA cells.
Discussion
Current antiretroviral therapies, including HAART, do
not completely eradicate latent reservoirs of HIV-1 from
patients, even though they suppress new HIV-1 replica-
tion effectively. The best way to eliminate this reservoir
completely is to reactivate HIV-1 latently infected cells
by inducing the expression of HIV-1 provirus. Many
studies have reported potential antireservoir therapies to
reactivate HIV-1 latently infected cells using HDAC
inhibitors [15-17], interleukin-7 (IL-7) [18,19], hexam-
ethyl-bisacetamide (HMBA) [20], and prostratin [21].
Eukaryotic genomes are organized into the chromatin
structure with repeated nucleosomes, which consist of
~146 base pairs of DNA wrapped around an octamer of
core histones (H3, H4, H2A, and H2B) [22]. Chromatin
structure can be varied by DNA methylation and post-
translational histone modifications. These modifications
are important for the regulation of cellular transcription,
DNA replication, and repair [5,6]. Although some
reports suggest that the chromatin structure at the HIV-
1 integration site and LTR region plays a major role in
HIV-1 postintegration latency [23,24], the molecular
linkage between HIV-1 latency and epigenetic control,
especially histone modifications, is not fully understood.
In this study, to identify the epigenetic relevance to
HIV-1 latency, we investigated core histones and histone
modification factors such as HDACs, which were
reported as critical factors in the maintenance of HIV-1
latency. As shown in Figure 1, the expression levels of
four core histones and HDACs did not exhibit signifi-
cantly differences in ACH2 and NCHA cells comparing
to those in their parent cells. These results suggest that
the protein amount of histones and HDACs in NCHA
cells may not be associated with HIV-1 latency even
though several studies have suggested HDACs-related
HIV-1 latency models [3,4].
Interestingly, H3K9me2/me3 and H3K27me2/me3
were highly enriched in HIV-latent cells. To determine
whether the enrichment of H3K9me3 and H3K27me3 in
NCHA cells was specific to certain genomic regions, the
distribution of histone methylations was examined in a
genome-wide level. H3K4me3 and H3K9ac showed high
(A) (B)
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Į-BMI1
Į-L a m i n  B
Į-RING2
Į-BMI1
Į-RING2 (Input)
Į-L a m i n  B
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Į-uH2A
Į-L a m i n  B
Figure 3 Induction of HIV-1 gene silencing by polycomb group proteins. A) Expression levels of EED, one of PRC2 components, were
measured by western blot. Thirty ug of nuclear extract were also used. The antibodies were indicated on the right. B) The expression levels of
polycomb group proteins, BMI1 and RING2, were examined by western blot. The right panel showed coimmunoprecipitation experiment,
immunoprecipitated with RING2 antibody and blotted with BMI1 antibody. C) Ubiquitylation levels of all cell lines were investigated by western
blot. Using 30 ug of nuclear extract and antibody against ubiqutylated histone H2A. Anti-laminB was used as a loading control.
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H3K27me3 were spread out over gene bodies and inter-
genic regions. However, these patterns were not signifi-
cantly changed in ACH2 and NCHA cells compared with
those of A3.01 cells. To identify the chromatin states of
HIV-1 proviral genome, we analyzed the histone methy-
lation patterns at H3K9 and H3K27. High enrichment of
H3K9me3 was observed in HIV-1 infected latent cells,
whereas there was no enrichment H3K27me3. Our
results show the possibility that the HIV-1 genome silen-
cing may be mainly caused by H3K9me3-mediated pro-
cess and the host cell genomes, especially in NCHA cells,
can be regulated by both H3K9me3 and H3K27me3.
These gene repression through histone methylations
were consistent with the previous report showing that
histone H3K27 trimethylation correlated with gene silen-
cing in human T cells [25].
Polycomb group (PcG)-proteins mediated gene silen-
cing is mainly established by histone H3K27 methyla-
tion. PcG proteins, which were first identified in
Drosophila melanogaster, are required for the mainte-
nance of HOX gene cluster repression during develop-
ment. They induce transcriptional gene silencing in
higher eukaryote and act as a global chromatin regula-
tor [26-28]. PcG proteins consist of two different com-
plexes, which are termed polycomb repressive complex
1( P R C 1 )a n d2( P R C 2 )[ 2 7 , 2 8 ] .P R C 1i sf o r m e db y
over 10 different proteins including BMI1 and
RING1A/B and ubiquitylates histone H2A by the E3
ubiquitin ligase activity of RING1A/B for silencing.
PRC2 is a smaller complex that comprises three main
proteins (EZH2, EED and SUZ12) and catalyzes his-
tone H3K27me3 [29,30]. Recently, it was also reported
that carboxy terminal domain of EED plays important
role in binding to tri-methyl lysine residue of histone
tails and is indispensable for the binding of PRC2 com-
plex to repressive marks [31]. According to the known
PcG-mediated silencing mechanism, PRC2 recruits
PRC1 to target genes via the binding of PRC1 to his-
tone H3K27me3. Subsequently, PRC1 catalyzes the
ubiquitylation of H2A and may lead to specific gene
silencing. Recently, it was reported that BMI1 play an
important role in the maintenance of HSV-1 latency
[32]. To elucidate the HIV-1 latency related to
H3K27me3 in more detail, we examined the expression
l e v e l so fE E D ,B M I 1a n dR I N G 2a l lo fw h i c hw e r e
enriched in NCHA cells and the interaction of BMI1
and RING2 was identified. Also, the ubiquitylation
levels of histone H2A in NCHA cells were increased
compared with the parent cells. These results suggest
that PRC-mediated repressive H3K27 methylation,
H3K27me3, and H2A ubiquitylation may contribute to
HIV-1 gene silencing in NCHA cells.
Conclusion
Newly established NCHA cells harboring latent HIV-1
showed the enrichment of histone H3K27 methylation,
histone H2A ubiquitylation, and PcG proteins expres-
sion. Therefore, our result demonstrates that tri-methy-
lation of H3K27 and H2A ubiquitylation via polycomb
r e p r e s s i v ec o m p l e x e ss h o u l db ei n v o l v e di nH I V - 1
latency and contribute to epigenetic gene silencing.
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